Levodopa-synergistic CBT intervention improves Parkinson’s disease with anxiety disorder by regulating the BDNF/PI3K/AKT pathway
CBT is an effective treatment for anxiety in patients with Parkinson's disease. Medications combined with CBT have been shown to be effective in improving depression, anxiety and quality of life in PDAD patients.
Authors
- Xinying Guan (ORCID: https://orcid.org/0000-0002-3180-6299)
- Zhenping Xian (ORCID: https://orcid.org/0000-0002-5420-3132)
- Shanshan Lu (ORCID: https://orcid.org/0000-0002-5438-8050)
- Dianshuai Gao (ORCID: https://orcid.org/0000-0001-8567-0238)
- Niu Ji
- Bingchao Xu (ORCID: https://orcid.org/0009-0007-1259-4765)
- Deqin Geng
Institutions
- Xuzhou Medical College (CN)
- The First People’s Hospital of Lianyungang (CN)
- Nanjing Jiangning Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Neurological Sciences
- Published
- 2025-02-12
- DOI
- https://doi.org/10.1007/s10072-025-07988-0
- Citations
- 1
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39